STAT+: In a high-profile misstep, the FDA backtracks on its ban on Juul

Did the FDA miss 6,000 pages of data from Juul when it decided to ban the company’s e-cigarettes? STAT unpacks the latest in the saga:

WASHINGTON — The FDA suddenly reversed course this week on its efforts to ban Juul e-cigarette sales, an embarrassing about-face that calls into question the reasoning behind the agency’s initial decision, experts said.

Tuesday evening, the Food and Drug Administration announced it was giving Juul’s application for its vaping products a second look because of “scientific issues … that warrant additional review.” The move came less than two weeks after the FDA made international headlines for ordering all of the vaping giant’s products off the market, prompting praise from lawmakers and advocates alike.

Continue to STAT+ to read the full story…